Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
518
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
St. Claraspital AG has been acquired by University Hospital Basel
Healthcare

St. Claraspital AG has been acquired by University Hospital Basel

University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care.

Learn more
Cerbios-Pharma has been acquired by HAS Healthcare
Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Learn more
Tem Group has been acquired by Instrumentation Laboratory
Healthcare

Tem Group has been acquired by Instrumentation Laboratory

The shareholders of Tem Group (TEM) have sold the company to Instrumentation Laboratory (IL). Financial details have not been disclosed.

Learn more
“We consider Oaklins to be a very reliable and flexible partner who has always supported us competently and in a goal-oriented manner, even in hectic situations. Oaklins has been an important sparring partner for us in various projects.”

Lukas Grimm

CFO, Doetsch Grether AG

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=CH&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Oaklins Healthcare M&A Report Q3 2025

Healthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valuations and regional dynamics.

Learn more

Talk to our local advisor

David Zürrer

Partner
Basel, Switzerland
Oaklins Switzerland

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael Goldman

Managing Director
New York, United States
Oaklins TM Capital